In 2017, seven newly diagnosed HIV cases linked to injecting drug use were reported, representing 1 % of new HIV cases with known transmission mode. The latest estimates on the prevalence of blood-borne viruses among people who inject drugs (PWID) are based on a small number of drug treatment centres in one region, with limited representativeness. To update these estimates, a seroprevalence study among PWID is being conducted in 2019.
|Data from 2014/15 (HIV) and from 2015/16 (HCV).|
|Sub-national||22.0 - 33.3||5.7 - 10.5|
Studies indicate that some high-risk use patterns, such as the sharing of needles or syringes, as well as ‘slamming’ (or injecting drugs in a sexual context) among men who have sex with men, have been observed among specific subgroups of people who use drugs in Belgium.